Skip to main content

Closed

OCGN: Ocugen, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-1483.9%

ROIC-157.6%

Financially safe

Stretched

Debt / equity5.74×

Interest coverage-13.2×

Current ratio1.86×

Ocugen, Inc.

OCGNNASDAQ Capital Market·USD·Closed

Ocugen, Inc.

OCGNNASDAQ·USD·Closed

$1.23

−2.38%

$1.23

−$0.03 (2.38%)

52W Range

17thpctl

Volume

0.53×avg

Mkt Cap

416.38MUSD

P/E

-5.3TTM

Div Yield

–ann

52W Range

17thpctl

Volume

0.53×avg

Market Cap

416.38MUSD

P/E Ratio

-5.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings